Single-Agent Oral Vinorelbine as First-Line Chemotherapy for Endocrine-Pretreated Breast Cancer With Bone Metastases and No Visceral Involvement: NORBREAST-228 Phase II Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Works by Steger, Guenther G.
Results: 25
1
2
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment.
- Published in:
- BMC Cancer, 2006, v. 6, p. 81, doi. 10.1186/1471-2407-6-81
- By:
- Publication type:
- Article
3
Analysis of trastuzumab and chemotherapy in advanced breast cancer after the failure of at least one earlier combination: An observational study.
- Published in:
- BMC Cancer, 2006, v. 6, p. 63, doi. 10.1186/1471-2407-6-63
- By:
- Publication type:
- Article
4
Palbociclib for the treatment of postmenopausal breast cancer – an update.
- Published in:
- Expert Opinion on Pharmacotherapy, 2016, v. 17, n. 2, p. 255, doi. 10.1517/14656566.2016.1133590
- By:
- Publication type:
- Article
5
Preoperative therapy with epidoxorubicin and docetaxel plus trastuzumab in patients with primary breast cancer: a pilot study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2004, v. 130, n. 7, p. 400, doi. 10.1007/S00432-004-0559-6
- By:
- Publication type:
- Article
6
BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapy.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
7
Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 903, doi. 10.1007/s00280-008-0682-1
- By:
- Publication type:
- Article
8
Oral vinorelbine alone or in combination with trastuzumab in advanced breast cancer: results from a pilot trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 5, p. 554, doi. 10.1007/s00280-005-0092-6
- By:
- Publication type:
- Article
9
Phase I/II trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patients with breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 2, p. 155, doi. 10.1007/s00280-002-0476-9
- By:
- Publication type:
- Article
10
Impact of Her-2-Targeted Therapy on Overall Survival in Patients With Her-2 Positive Metastatic Breast Cancer.
- Published in:
- Breast Journal, 2013, v. 19, n. 2, p. 149, doi. 10.1111/tbj.12070
- By:
- Publication type:
- Article
11
Effects of Denosumab in Patients With Bone Metastases With and Without Previous Bisphosphonate Exposure.
- Published in:
- Journal of Bone & Mineral Research, 2010, v. 25, n. 3, p. 440, doi. 10.1359/jbmr.090810
- By:
- Publication type:
- Article
12
Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast Cancer.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
13
Treatment of Bone Metastases in Patients with Advanced Breast Cancer.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
14
Trends and Novel Approaches in Neoadjuvant Treatment of Breast Cancer.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
15
Capecitabine and Vinorelbine as an All-Oral Chemotherapy in HER2-Negative Locally Advanced and Metastatic Breast Cancer.
- Published in:
- Breast Care, 2010, v. 5, n. 3, p. 158, doi. 10.1159/000314214
- By:
- Publication type:
- Article
16
The Role of Supportive Therapy in the Era of Modern Adjuvant Treatment – Current and Future Tools.
- Published in:
- Breast Care, 2009, v. 4, n. 3, p. 167, doi. 10.1159/000223360
- By:
- Publication type:
- Article
17
Analysis of microdialysates from cancer patients by capillary electrophoresis.
- Published in:
- Electrophoresis, 1998, v. 19, n. 16/17, p. 2981, doi. 10.1002/elps.1150191630
- By:
- Publication type:
- Article
18
Influence of the American ODAC Statement on Austrian Bevacizumab Prescribing Practice for Metastatic Breast Cancer.
- Published in:
- Oncologist, 2012, v. 17, n. 7, p. e13, doi. 10.1634/theoncologist.2012-0115
- By:
- Publication type:
- Article
19
HER-2-Positive Breast Cancer: Hope Beyond Trastuzumab.
- Published in:
- BioDrugs, 2007, v. 21, n. 2, p. 69, doi. 10.2165/00063030-200721020-00001
- By:
- Publication type:
- Article
20
Current standards in the treatment of metastatic breast cancer with focus on Lapatinib: a review by a Central European Consensus Panel.
- Published in:
- 2010
- By:
- Publication type:
- Report
21
Trastuzumab in the management of early and advanced stage breast cancer.
- Published in:
- Biologics: Targets & Therapy, 2007, v. 1, n. 1, p. 19
- By:
- Publication type:
- Article
22
Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion.
- Published in:
- Therapeutic Advances in Medical Oncology, 2011, v. 3, n. 5, p. 233, doi. 10.1177/1758834011412656
- By:
- Publication type:
- Article
23
Expression of thymidine phosphorylase in peripheral blood cells of breast cancer patients is not increased by paclitaxel.
- Published in:
- BMC Clinical Pharmacology, 2007, v. 7, p. 7, doi. 10.1186/1472-6904-7-7
- By:
- Publication type:
- Article
24
Folate Absorption in Crohn's Disease.
- Published in:
- Digestion, 1994, v. 55, n. 4, p. 234, doi. 10.1159/000201153
- By:
- Publication type:
- Article
25
Dissecting progressive stages of 5-fluorouracil resistance in vitro using RNA expression profiling.
- Published in:
- International Journal of Cancer, 2004, v. 112, n. 2, p. 200, doi. 10.1002/ijc.20401
- By:
- Publication type:
- Article